Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl V Clemons

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Medical Mycology|July 3, 2015
Changing of the Guard--Greetings from the New Editor in ChiefKarl V Clemons
Medical Mycology|November 10, 2018
Animal models of Aspergillus infection in preclinical trials, diagnostics and pharmacodynamics: What can we learn from them?Karl V Clemons, David A Stevens
Current Opinion in Infectious Diseases|June 29, 2006
Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directionsKarl V Clemons, David A Stevens
The Korean Journal of Internal Medicine|July 19, 2013
Vaccines against CoccidioidesHee Jung Yoon, Karl V Clemons
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Orogastrointestinal model of mucosal and disseminated candidiasisKarl V Clemons, David A Stevens
Medical Mycology|June 30, 2006
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosisKarl V Clemons, David A Stevens
Antimicrobial Agents and Chemotherapy|February 26, 2004
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosisKarl V Clemons, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Azole therapy of clinical and experimental coccidioidomycosisDavid A Stevens, Karl V Clemons
Expert Review of Anti-Infective Therapy|December 5, 2008
Third Advances Against Aspergillosis Meeting 2008David A Stevens, Karl V Clemons
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2017
Heat-Killed Yeast as a Pan-Fungal VaccineMarife Martinez, Karl V Clemons, David A Stevens
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Medical Mycology|July 3, 2015
Changing of the Guard--Greetings from the New Editor in ChiefKarl V Clemons
Medical Mycology|November 10, 2018
Animal models of Aspergillus infection in preclinical trials, diagnostics and pharmacodynamics: What can we learn from them?Karl V Clemons, David A Stevens
Current Opinion in Infectious Diseases|June 29, 2006
Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directionsKarl V Clemons, David A Stevens
The Korean Journal of Internal Medicine|July 19, 2013
Vaccines against CoccidioidesHee Jung Yoon, Karl V Clemons
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Orogastrointestinal model of mucosal and disseminated candidiasisKarl V Clemons, David A Stevens
Medical Mycology|June 30, 2006
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosisKarl V Clemons, David A Stevens
Antimicrobial Agents and Chemotherapy|February 26, 2004
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosisKarl V Clemons, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Azole therapy of clinical and experimental coccidioidomycosisDavid A Stevens, Karl V Clemons
Expert Review of Anti-Infective Therapy|December 5, 2008
Third Advances Against Aspergillosis Meeting 2008David A Stevens, Karl V Clemons
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2017
Heat-Killed Yeast as a Pan-Fungal VaccineMarife Martinez, Karl V Clemons, David A Stevens
Pageof 12